The federal government has procured more doses of AstraZeneca's COVID-19 monoclonal antibody for the National Medical Stockpile, but the PBAC has rejected it for reimbursement through the PBS, for a second time.
New COVID-19 sub-variants an emerging challenge for high-risk patients
January 30, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
SCENESSE gains Canadian approval offering long term protection for patients with rare disorder
July 13, 2026 - - Australian Biotech -
Patrys and Yale agree revenue share to advance deoxymab platform
July 13, 2026 - - Australian Biotech -
What is it with this organisation's obsession with pharmacy and Europe?
July 13, 2026 - - Latest News -
Mesoblast reports strong cell therapy revenue as first year as uptake grows
July 13, 2026 - - Latest News -
The inevitability of disappointment over a reform process that has devolved into word games
July 12, 2026 - - Latest News -
The 'Dispatched' Podcast - Series 5, Ep 23
July 10, 2026 - - Podcast -
Disruption is the overdue remedy and how this debate can revitalise the PBS
July 10, 2026 - - Latest News

